Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Symphony Triple A Study: Using Symphony as an Adjunct to Histopathologic Parameters When the Doctor is Ambivalent About the Administration and Type of Adjunctive Systemic Therapy

NCT02209857 is registered in ClinicalTrials.gov with Diakonessenhuis, Utrecht as lead sponsor.

NCT NCT02209857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02209857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Symphony Triple A Study: Using Symphony as an Adjunct to Histopathologic Parameters When the Doctor is Ambivalent About the Administration and Type of Adjunctive Systemic Therapy
Lead sponsor
Diakonessenhuis, Utrecht
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2016
Enrollment
660 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

breastcancer, invasive breast carcinoma by gene expression profile